高级检索
当前位置: 首页 > 详情页

Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Dept Global Hlth, Beijing 100730, Peoples R China [2]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing 100021, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing, Peoples R China [4]Xinjiang Med Univ, Affiliated Canc Hosp, Canc Res Inst, Urumqi, Peoples R China [5]Capital Med Univ, Dept Obstet & Gynecol, Beijing Tongren Hosp, Beijing, Peoples R China [6]Ordos Maternal & Child Hlth Care Hosp, Deans Off, Ordos, Inner Mongolia, Peoples R China [7]Ikinholo Banner Maternal & Child Care Ctr, Womens Hlth Dept, Ordos, Inner Mongolia, Peoples R China [8]Otog Front Banner Maternal & Child Care Ctr, Womens Hlth Dept, Ordos, Inner Mongolia, Peoples R China [9]Dalad Banner Maternal & Child Care Ctr, Deans Off, Ordos, Inner Mongolia, Peoples R China [10]Jungar Banner Maternal & Child Care Ctr, Womens Hlth Dept, Ordos, Inner Mongolia, Peoples R China [11]Otog Banner Maternal & Child Care Ctr, Womens Hlth Dept, Ordos, Inner Mongolia, Peoples R China [12]Hangjin Banner Maternal & Child Care Ctr, Dept Obstet & Gynecol, Ordos, Inner Mongolia, Peoples R China [13]Uxin Banner Maternal & Child Care Ctr, Womens Hlth Dept, Ordos, Inner Mongolia, Peoples R China [14]Dongsheng Dist Maternal & Child Care Ctr, Dept Obstet & Gynecol, Ordos, Inner Mongolia, Peoples R China
出处:
ISSN:

摘要:
Importance Limited evidence supports the performance of human papillomavirus (HPV) DNA testing as a primary screening method, followed by triage with visual inspection with acetic acid, in areas with limited health care resources, as suggested by the 2021 World Health Organization guidelines. Objective To evaluate the performance of visual inspection with acetic acid and Lugol iodine as a triage method for detecting cervical precancerous lesions among HPV-positive women in 1 visit. Design, Setting, and Participants This cohort study examined the implementation of a government-led cervical cancer screening program conducted from January 1, 2016, to December 31, 2020, in Ordos City, China. Female residents, aged 35 to 64 years, who understood the screening procedures and voluntarily participated were included in the study. Women were excluded if they reported never having had sexual intercourse, were pregnant, had a hysterectomy, or had ever undergone treatment for cervical lesions. Statistical analysis was conducted from December 2022 to December 2023. Exposures The program used the careHPV DNA assay as the primary screening method, and immediate triage was performed by visual inspection if HPV screening results were positive, with a 5-year screening interval. A colposcopy was performed for the women who had suspected cancer on visual inspection results or who were HPV positive and had abnormal visual inspection results, all in 1 visit. Main Outcomes and Measures The rate of compliance with colposcopy and the detection rate of cervical intraepithelial neoplasia grade 2 or higher (CIN2+). Results The study included 187 863 women (median age, 46 years [IQR, 40-52 years]) who participated in the program and had valid HPV test results. The overall prevalence of HPV positivity was 12.8% (24 070 of 187 863), and the adherence to triage with visual inspection among HPV-positive women was 93.9% (22 592 of 24 070). Among HPV-positive women, the rate of compliance with colposcopy was 65.6% (2714 of 4137), and the CIN2+ detection rate was 2.8% (643 of 22 592). Conclusions and Relevance The findings of this cohort study suggest that the implementation of HPV testing, visual inspection, and colposcopy within 1 visit may mitigate losses to follow-up, detect precancerous lesions, and hold significant implications for screening in comparable areas with limited health care resources.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2022]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [2]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing 100021, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23549 今日访问量:0 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)